SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
OUTCOMES OF SARS-CoV-2 INFECTION
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
9 of
9
|
HOST FACTORS ASSOCIATED WITH PERSISTENT SARS-COV-2 VIRAL RNA IN COVID-19 OUTPATIENTS (ABSTRACT
209)
Annukka A. R. Antar
Johns Hopkins University, Baltimore, USA
EARLY CORE SIGNATURE OF SOLUBLE FACTORS IN MILD TO MODERATE SARS-COV-2 INFECTION (ABSTRACT
210)
Miguel Marin
IrsiCaixa AIDS Research Institute, Badalona, Barcelona, Spain
FIRST HIGH-DIMENSIONAL EXAMINATION OF INTESTINAL BIOPSIES IN PATIENTS WITH COVID-19 (ABSTRACT
211)
Divya Jha
Icahn School of Medicine at Mount Sinai, New York, NY, USA
INTESTINAL PERMEABILITY AND MICROBIAL TRANSLOCATION ARE INCREASED IN SEVERE COVID-19 (ABSTRACT
212)
Netanya Sandler Utay
University of Texas Health Science Center at Houston, Houston, TX, USA
SARS-COV-2 INFECTS AND REPLICATES IN CELLS OF THE ENDOCRINE AND EXOCRINE PANCREAS (ABSTRACT
213)
Janis Müller
Ulm University Medical Center, Ulm, Germany
UNIQUE CARDIOMETABOLIC IMMUNE SIGNATURES IN SEVERE-COVID-19 PATIENTS AND SURVIVORS (ABSTRACT
214)
Namal Liyanage
The Ohio State University, Columbus, OH, USA
IL10 AND B CELLS COOPERATE TO PREDICT SARS-COV-2 DISEASE SEVERITY (ABSTRACT
215)
Susan Pereira Ribeiro
Emory University, Atlanta, GA, USA
RECRUITMENT OF SPECIFIC MONOCYTE AND DC SUBSETS TO THE LUNG DURING SEVERE COVID-19 (ABSTRACT
216)
Ildefonso Sanchez Cerrillo
Hospital La Princesa, Madrid, Madrid, Spain
SARS-COV-2 ORF3A ACTIVATES THE NLRP3 INFLAMMASOME (ABSTRACT
217)
Kimberly E Rousseau
Johns Hopkins University, Baltimore, MD, USA
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
9 of
9
|
